Analysen von Mark Purcell

28.10.21 Sanofi Overweight Morgan Stanley
17.09.21 AstraZeneca Overweight Morgan Stanley
17.09.21 MorphoSys Overweight Morgan Stanley
17.09.21 Bayer Overweight Morgan Stanley
27.07.21 Novartis Overweight Morgan Stanley
26.01.21 Novartis overweight Morgan Stanley
08.01.21 Sanofi overweight Morgan Stanley
08.01.21 Novartis overweight Morgan Stanley
08.01.21 Bayer overweight Morgan Stanley
07.12.20 AstraZeneca overweight Morgan Stanley
21.10.20 Novartis overweight Morgan Stanley
14.09.20 Bayer overweight Morgan Stanley
01.09.20 Novartis overweight Morgan Stanley
10.08.20 Bayer overweight Morgan Stanley
10.08.20 Roche overweight Morgan Stanley
28.07.20 Roche overweight Morgan Stanley
25.06.20 Bayer overweight Morgan Stanley
09.06.20 Sanofi overweight Morgan Stanley
27.04.20 Roche overweight Morgan Stanley
22.04.20 Bayer overweight Morgan Stanley
03.03.20 Roche overweight Morgan Stanley
18.02.20 Roche overweight Morgan Stanley
04.02.20 Sanofi overweight Morgan Stanley
06.01.20 Bayer overweight Morgan Stanley
06.01.20 Roche overweight Morgan Stanley
06.01.20 Sanofi overweight Morgan Stanley
17.10.19 Roche overweight Morgan Stanley
16.10.19 Roche overweight Morgan Stanley
23.09.19 Sanofi overweight Morgan Stanley
30.04.19 Roche overweight Morgan Stanley
11.02.19 Roche overweight Morgan Stanley
14.12.18 Roche overweight Morgan Stanley
05.05.15 GSK overweight Barclays Capital
01.04.15 GSK overweight Barclays Capital
01.04.15 Roche overweight Barclays Capital
16.01.15 GSK kaufen Barclays Capital
16.01.15 Roche overweight Barclays Capital
16.10.14 Sanofi overweight Barclays Capital
15.10.14 Roche overweight Barclays Capital
25.07.14 Roche overweight Barclays Capital
16.04.14 Roche overweight Barclays Capital
10.03.14 Sanofi overweight Barclays Capital
10.03.14 Roche overweight Barclays Capital
28.07.11 GSK overweight Barclays Capital